# Limiting AAA With Metformin (LIMIT) Trial

> **NCT04500756** · PHASE2 · RECRUITING · sponsor: **Stanford University** · enrollment: 314 (estimated)

## Conditions studied

- Abdominal Aortic Aneurysm

## Interventions

- **DRUG:** Metformin
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT04500756
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-02-28
- **Primary completion:** 2028-06-30
- **Final completion:** 2028-06-30
- **Target enrollment:** 314 (ESTIMATED)
- **Last updated:** 2025-04-18

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04500756

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04500756, "Limiting AAA With Metformin (LIMIT) Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04500756. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*